Beranda › Sindrom Bronkiolitis Obliterans › Massachusetts
Uji klinis Sindrom Bronkiolitis Obliterans di Massachusetts
14 studi untuk Sindrom Bronkiolitis Obliterans mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07011810A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Menerima pesertaFase 2
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07116031Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT05996627A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Massachusetts Cancer Research Center, Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05919511Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06991361Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Menerima pesertaStudi observasional
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT07434869A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Massachusetts General Hospital, Boston
Menerima pesertaFase 2
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT04710576BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05922761A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06615050Direct to Patient Minimal Risk Biospecimen and Data Collection Research
- Joined Bio, Lexington
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT07128966Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT05236062A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.